Filing Details
- Accession Number:
- 0001209191-14-040164
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-10 16:07:43
- Reporting Period:
- 2014-06-06
- Filing Date:
- 2014-06-10
- Accepted Time:
- 2014-06-10 16:07:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 31791 | Perkinelmer Inc | PKI | Laboratory Analytical Instruments (3826) | 042052042 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1224110 | F Robert Friel | 940 Winter Street Waltham MA 02451 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-06-06 | 94,987 | $25.02 | 627,297 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-06-06 | 94,987 | $46.44 | 532,310 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-06-09 | 29,871 | $25.02 | 562,181 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-06-09 | 29,871 | $47.51 | 532,310 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | NQ Stock Option (right to buy) | Disposition | 2014-06-06 | 94,987 | $0.00 | 94,987 | $25.02 |
| Common Stock | NQ Stock Option (right to buy) | Disposition | 2014-06-09 | 29,871 | $0.00 | 29,871 | $25.02 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 29,871 | 2015-01-29 | No | 4 | M | Direct | |
| 0 | 2015-01-29 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Friel on March 7, 2014 and amended May 5, 2014.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $47.500 to $47.520. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $47.500 to $47.541. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- This option became exercisable in three equal annual installments beginning on January 29, 2009, which was the first anniversary of the date on which the option was granted.
Billionaire Hedge Funds
